Clinical trial
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
NCT06257693
Study timeline
Study start (actual)2024-06-21Date precision: day
Registry last updated2026-08-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Adenocarcinomaunresolved
Interventions
enzalutamideDRUG · verified · RxNorm: enzalutamide
Sponsors & collaborators
Alessa Therapeutics Inc.lead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06257693 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.